Epithelial specific ubiquitination events
上皮特异性泛素化事件
基本信息
- 批准号:7142202
- 负责人:
- 金额:$ 38.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The intestinal inflammatory response is mediated in large part by synthetic upregulation of secreted cytokines and other inflammatory effector molecules. These inflammatory mediators are activated at the transcriptional level by the action of DNA binding transcription factors such as NF-kB. NF-kB itself is activated by a rapid post translational pathway involving sequential phosphorylation, ubiquitination and degradation of the inhibitor molecule, IkB. Unique among tissues, the intestinal epithelia functions in close contact with a diverse prokaryotic flora. There is increasing interest in the effects, both deleterious and beneficial, of these bacteria on the host epithelia. In this proposal, we describe enteric commensal bacterial strains that repress activation of the key NF-kB regulator by influencing a rate-limiting biochemical step, ubiquitination. Ubiquitination is an inducible covalent modification with a well defined role in protein turnover and degradation, and emerging roles in signal transduction, endocytic trafficking and other cellular functions. Bacteria and their products may influence covalent modifications necessary for activation of the enzymes responsible for ubiquitination of IkB and potentially other proteins involved in epithelial signaling. In other work, we have identified candidate effector molecules in enteric pathogens that are potent inhibitors of NFkB and likely act as deubiquitinating enzymes. We hypothesize these proteins will have profound effects on eukaryotic proinflammatory pathways and control of cellular apoptosis.
Our overall hypothesis is that enteric bacteria, both commensal inhabitants of the intestine and known pathogens, have evolved mechanisms to modulate epithelial signaling pathways by influencing the eukaryotic ubiquitin system. Depending the specific biological context, the consequences of these interactions may by causal of infectious and idiopathic colitis, and/or may contribute to the physiology and overall health of the intestine. This proposal describes a variety of in vitro and in vivo experimental methods to study how bacteria influence the ubiquitination system in the intestinal epithelia, especially as it relates to the activation of the NF-kB and apoptotic pathways. Elucidation of these host-microbe interactions will increase our understanding of the epithelial and bacterial factors involved in human enterocolitis, and potentially in idiopathic inflammatory intestinal disease.
描述(由申请人提供):肠道炎症反应在很大程度上由分泌的细胞因子和其他炎症效应分子的合成上调介导。这些炎症介质在转录水平上通过DNA结合转录因子如NF-κ B的作用而被激活。NF-kB本身通过快速翻译后途径激活,该途径涉及抑制剂分子IkB的连续磷酸化、泛素化和降解。肠上皮细胞在组织中是独特的,其功能与多种原核植物群密切接触。人们越来越关注这些细菌对宿主上皮细胞的有害和有益的影响。在这个提议中,我们描述了肠道细菌菌株,通过影响限速生化步骤,泛素化抑制关键NF-κ B调节剂的激活。泛素化是一种可诱导的共价修饰,在蛋白质周转和降解中具有明确的作用,并且在信号转导、内吞运输和其他细胞功能中具有新兴作用。细菌及其产物可能影响负责IkB泛素化的酶和参与上皮信号传导的潜在其他蛋白质的活化所必需的共价修饰。在其他工作中,我们已经确定了肠道病原体中的候选效应分子,它们是NFkB的有效抑制剂,并可能作为去泛素化酶。我们假设这些蛋白质将对真核细胞的促炎通路和细胞凋亡的控制产生深远的影响。
我们的总体假设是,肠道细菌,肠道和已知的病原体的寄生虫,已经进化出的机制,通过影响真核泛素系统来调节上皮细胞的信号通路。根据特定的生物学背景,这些相互作用的后果可能是感染性和特发性结肠炎的原因,和/或可能有助于肠道的生理学和整体健康。该提案描述了各种体外和体内实验方法来研究细菌如何影响肠上皮细胞中的泛素化系统,特别是当它涉及NF-κ B和凋亡途径的激活时。阐明这些宿主-微生物相互作用将增加我们对人类小肠结肠炎中涉及的上皮和细菌因素的理解,并可能在特发性炎症性肠病中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew S Neish其他文献
Multi-Center Clinical Validation of a Mass Spectrometry Immunoassay for the Diagnosis and Monitoring of Multiple Myeloma and Associated Disorders
- DOI:
10.1182/blood-2023-189050 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Oscar Berlanga;Jane Birtwistle;Syreeta Allen;Gemma Malin;Cristina Simion;Habib El-Khoury;Julia Colchie;Luca Bertamini;Grace Fleming;Erica M. Horowitz;Irene M. Ghobrial;Kaleb B McLendon;John Roback;Andrew S Neish;Sarah K Grewal;Gabriella Lakos - 通讯作者:
Gabriella Lakos
Andrew S Neish的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew S Neish', 18)}}的其他基金
Role of Gut Inflammation and Immunity on Proteostasis, Noradrenergic Degeneration and AD risk
肠道炎症和免疫对蛋白质稳态、去甲肾上腺素能变性和 AD 风险的作用
- 批准号:
10139341 - 财政年份:2020
- 资助金额:
$ 38.25万 - 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
- 批准号:
7350883 - 财政年份:2007
- 资助金额:
$ 38.25万 - 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
- 批准号:
7564067 - 财政年份:2007
- 资助金额:
$ 38.25万 - 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
- 批准号:
8037214 - 财政年份:2007
- 资助金额:
$ 38.25万 - 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
- 批准号:
7211965 - 财政年份:2007
- 资助金额:
$ 38.25万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 38.25万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:














{{item.name}}会员




